Publications
Detailed Information
p15INK4b methylation correlates with thrombocytopenia, blast percentage, and survival in myelodysplastic syndromes in a dose dependent manner: Quantitation using pyrosequencing study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yoon, Jong Hyun | - |
dc.contributor.author | Lee, Dong Soon | - |
dc.contributor.author | Kim, Miyoung | - |
dc.contributor.author | Kim, Song-yee | - |
dc.contributor.author | Kim, Young Tae | - |
dc.contributor.author | Hwang, Sang Mee | - |
dc.contributor.author | Park, Hyun-Kyung | - |
dc.contributor.author | Oh, Bora | - |
dc.contributor.author | She, Cha Ja | - |
dc.contributor.author | Yoon, Sung Soo | - |
dc.contributor.author | Yang, Inchul | - |
dc.date.accessioned | 2012-05-23T01:39:50Z | - |
dc.date.available | 2012-05-23T01:39:50Z | - |
dc.date.issued | 2010-06 | - |
dc.identifier.citation | LEUKEMIA RESEARCH; Vol.34 6; 718-722 | ko_KR |
dc.identifier.issn | 0145-2126 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76297 | - |
dc.description.abstract | We investigated how the quantity of p15INK4b methylation related to International Prognosic Scoring System variables and survival in 74 patients with de novo myelodysplastic syndrome (MDS). Pyrosequencing of 11 consecutive CpG sites of the p15INK4b promotor region was performed, with the extent of CpG cytosine methylation assessed in terms of methylation level (MtL). Patients with >5% bone marrow blasts had higher MtL than patients with <5% blasts (10.1% vs. 6.1%, p = 0.030, respectively). Methylation was not associated with chromosomal aberrations. The MtL of patients with thrombocytopenia were higher than patients without thrombocytopenia (11.2% vs. 6.2%, p = 0.036, respectively); they were higher in patients with cytopenias in >= 2 lineages than in patients with either unilineage or no cytopenia (9.8% vs. 4.1%, p = 0.036, respectively). The survival of patients with >7% MtL was worse than patients with <7% MtL (p = 0.031). Heavy p15INK4b methylation in MDS is associated with IPSS predictors of poor prognosis and adverse survival. Crown Copyright (C) 2009 Published by Elsevier Ltd. All rights reserved. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | ko_KR |
dc.subject | p15INK4b | ko_KR |
dc.subject | Prognosis | ko_KR |
dc.subject | Myelodysplastic syndromes | ko_KR |
dc.subject | Methylation | ko_KR |
dc.subject | Pyrosequencing | ko_KR |
dc.title | p15INK4b methylation correlates with thrombocytopenia, blast percentage, and survival in myelodysplastic syndromes in a dose dependent manner: Quantitation using pyrosequencing study | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 김미영 | - |
dc.contributor.AlternativeAuthor | 오보라 | - |
dc.contributor.AlternativeAuthor | 김송이 | - |
dc.contributor.AlternativeAuthor | 박현경 | - |
dc.contributor.AlternativeAuthor | 황상미 | - |
dc.contributor.AlternativeAuthor | 김영태 | - |
dc.contributor.AlternativeAuthor | 양인철 | - |
dc.contributor.AlternativeAuthor | 윤성수 | - |
dc.contributor.AlternativeAuthor | 윤종현 | - |
dc.contributor.AlternativeAuthor | 이동순 | - |
dc.identifier.doi | 10.1016/j.leukres.2009.09.007 | - |
dc.citation.journaltitle | LEUKEMIA RESEARCH | - |
dc.description.citedreference | Gao W, 2008, CARCINOGENESIS, V29, P1901, DOI 10.1093/carcin/bgn170 | - |
dc.description.citedreference | Nimer SD, 2008, BLOOD, V111, P4841, DOI 10.1182/blood-2007-08-078139 | - |
dc.description.citedreference | Lee ES, 2008, CLIN CANCER RES, V14, P2664, DOI 10.1158/1078-0432.CCR-07-1232 | - |
dc.description.citedreference | Yang R, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-124 | - |
dc.description.citedreference | MUFTI GJ, 2008, CANC CONTROL, V15, pS14 | - |
dc.description.citedreference | Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314 | - |
dc.description.citedreference | Brakensiek K, 2007, CLIN CHEM, V53, P17, DOI 10.1373/clinchem.2007.072629 | - |
dc.description.citedreference | McDermott KM, 2006, PLOS BIOL, V4, P350, DOI 10.1371/journal/pbio.0040051 | - |
dc.description.citedreference | Shaw RJ, 2006, BRIT J CANCER, V94, P561, DOI 10.1038/sj.bjc.6602972 | - |
dc.description.citedreference | Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821 | - |
dc.description.citedreference | Uchida T, 1997, BLOOD, V90, P1403 | - |
dc.description.citedreference | Quesnel B, 1998, BLOOD, V91, P2985 | - |
dc.description.citedreference | Ronaghi M, 1998, SCIENCE, V281, P363 | - |
dc.description.citedreference | Cameron EE, 1999, BLOOD, V94, P2445 | - |
dc.description.citedreference | CZEPULKOWSKI B, 2001, HUMAN CYTOGENETICS M, P1 | - |
dc.description.citedreference | Tien HF, 2001, BRIT J HAEMATOL, V112, P148 | - |
dc.description.citedreference | Uhlmann K, 2002, ELECTROPHORESIS, V23, P4072 | - |
dc.description.citedreference | Au WY, 2003, BRIT J HAEMATOL, V120, P1062 | - |
dc.description.citedreference | THIELE J, 1991, J CLIN PATHOL, V44, P300 | - |
dc.description.citedreference | Colella S, 2003, BIOTECHNIQUES, V35, P146 | - |
dc.description.citedreference | Chim CS, 2003, ANN HEMATOL, V82, P738, DOI 10.1007/s00277-003-0744-8 | - |
dc.description.citedreference | SHAFFER LG, 2005, ISCN 2005 INT SYSTEM | - |
dc.description.citedreference | MARSH S, 2005, METH MOL B, V311, P97 | - |
dc.description.citedreference | Dupont JM, 2004, ANAL BIOCHEM, V333, P119, DOI 10.1016/j.ab.2004.05.007 | - |
dc.description.citedreference | Cottrell SE, 2004, CLIN BIOCHEM, V37, P595, DOI 10.1016/j.clinbiochem.2004.05.010 | - |
dc.description.citedreference | LIST AF, 2004, AM SOC HEMATOL ED PR, P297 | - |
dc.description.tc | 1 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.